BRPI0713343A2 - Composições farmacêuticas contendo anticorpo monoclonal anti-idiolípico anti-ca-125 e alumínio - Google Patents

Composições farmacêuticas contendo anticorpo monoclonal anti-idiolípico anti-ca-125 e alumínio Download PDF

Info

Publication number
BRPI0713343A2
BRPI0713343A2 BRPI0713343-0A BRPI0713343A BRPI0713343A2 BR PI0713343 A2 BRPI0713343 A2 BR PI0713343A2 BR PI0713343 A BRPI0713343 A BR PI0713343A BR PI0713343 A2 BRPI0713343 A2 BR PI0713343A2
Authority
BR
Brazil
Prior art keywords
aluminum
pharmaceutical compositions
monoclonal antibody
compositions containing
idiolipic
Prior art date
Application number
BRPI0713343-0A
Other languages
English (en)
Inventor
Flemming
Jens
Gröger
Karsten
Schmitz
Reinhard
Manzini
Stefano
Original Assignee
Menarini International Operations Luxembourg S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini International Operations Luxembourg S.A. filed Critical Menarini International Operations Luxembourg S.A.
Publication of BRPI0713343A2 publication Critical patent/BRPI0713343A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39566—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against immunoglobulins, e.g. anti-idiotypic antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

COMPOSIçõES FARMACêUTICAS CONTENDO ANTICORPO NONOCLONAL ANTI-.IDIOTìPICO ANTI-CA-125 E ALUMìNIO. A presente invenção se refere a uma composição farmacêutica para administração parenteral como vacina compreendendo um anticorpo monoclonal e, como adjuvante, um derivado de alumínio.
BRPI0713343-0A 2006-06-29 2007-06-28 Composições farmacêuticas contendo anticorpo monoclonal anti-idiolípico anti-ca-125 e alumínio BRPI0713343A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000163A ITFI20060163A1 (it) 2006-06-29 2006-06-29 Composizione farmaceutica contenente un anticorpo monoclonale anti idiotipico anti-ca-125 ed alluminio
ITFI2006A000163 2006-06-29
PCT/EP2007/056465 WO2008000789A2 (en) 2006-06-29 2007-06-28 Pharmaceutical compositions containing monoclonal anti idiotypic anti-ca-125 antibody and aluminium derivatives

Publications (1)

Publication Number Publication Date
BRPI0713343A2 true BRPI0713343A2 (pt) 2012-03-13

Family

ID=37439367

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0713343-0A BRPI0713343A2 (pt) 2006-06-29 2007-06-28 Composições farmacêuticas contendo anticorpo monoclonal anti-idiolípico anti-ca-125 e alumínio

Country Status (35)

Country Link
US (2) US20100040625A1 (pt)
EP (2) EP2040749B1 (pt)
JP (1) JP2009541448A (pt)
KR (1) KR20090024240A (pt)
CN (1) CN101478987A (pt)
AP (1) AP2009004741A0 (pt)
AR (1) AR061364A1 (pt)
AT (1) ATE502649T1 (pt)
AU (1) AU2007263690A1 (pt)
BR (1) BRPI0713343A2 (pt)
CA (1) CA2655733A1 (pt)
CL (1) CL2007001888A1 (pt)
CR (1) CR10589A (pt)
CY (1) CY1111527T1 (pt)
DE (1) DE602007013402D1 (pt)
DK (1) DK2040749T3 (pt)
EA (1) EA015543B1 (pt)
EC (1) ECSP099089A (pt)
ES (1) ES2363616T3 (pt)
HK (1) HK1126417A1 (pt)
HR (1) HRP20110413T1 (pt)
IL (1) IL196148A0 (pt)
IT (1) ITFI20060163A1 (pt)
MA (1) MA30691B1 (pt)
MX (1) MX2008016059A (pt)
NO (1) NO20090395L (pt)
PE (1) PE20080269A1 (pt)
PL (1) PL2040749T3 (pt)
PT (1) PT2040749E (pt)
RS (1) RS51683B (pt)
SI (1) SI2040749T1 (pt)
TN (1) TNSN08485A1 (pt)
UA (1) UA95806C2 (pt)
WO (1) WO2008000789A2 (pt)
ZA (1) ZA200900563B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160279239A1 (en) 2011-05-02 2016-09-29 Immunomedics, Inc. Subcutaneous administration of anti-cd74 antibody for systemic lupus erythematosus and autoimmune disease
US20160355591A1 (en) 2011-05-02 2016-12-08 Immunomedics, Inc. Subcutaneous anti-hla-dr monoclonal antibody for treatment of hematologic malignancies
ITFI20060163A1 (it) * 2006-06-29 2006-09-28 Menarini Internat Operations Luxembourg Sa Composizione farmaceutica contenente un anticorpo monoclonale anti idiotipico anti-ca-125 ed alluminio
CA2831572C (en) 2011-05-02 2019-11-26 Immunomedics, Inc. Ultrafiltration concentration of allotype selected antibodies for small-volume administration
WO2018187074A1 (en) 2017-04-03 2018-10-11 Immunomedics, Inc. Subcutaneous administration of antibody-drug conjugates for cancer therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5127731B1 (pt) * 1971-05-12 1976-08-14
FR2565825B1 (fr) * 1984-06-15 1990-07-13 Centre Nat Rech Scient Vaccin contre les maladies dues a des microorganismes tels que des mycoplasmes, sa preparation et membranes de microorganismes en tant que principe actif
ATE189122T1 (de) * 1993-05-27 2000-02-15 Uwe Dr Med Wagner Monoklonale anti-idiotypische anti - ca125 antikörper und sie enthaltende pharmazeutische zusammensetzung
US5718904A (en) * 1995-06-02 1998-02-17 American Home Products Corporation Adjuvants for viral vaccines
US5690942A (en) * 1995-06-02 1997-11-25 American Home Products Corporation Adjuvants for viral vaccines
GB9808485D0 (en) * 1998-04-21 1998-06-17 Univ Cambridge Tech Improvements relating to immunotherapy
US6586403B1 (en) * 2000-07-20 2003-07-01 Salpep Biotechnology, Inc. Treating allergic reactions and inflammatory responses with tri-and dipeptides
US6585981B1 (en) * 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
CU23007A1 (es) * 2001-04-06 2004-12-17 Ct De Inmunologia Molecular Ct De Inmunologia Mole Combinaciones inmunoterapéuticas para el tratamiencombinaciones inmunoterapéuticas para el tratamiento de tumores que sobre-expresan gangliósidos to de tumores que sobre-expresan gangliósidos
US7537767B2 (en) * 2003-03-26 2009-05-26 Cytis Biotechnology Ag Melan-A- carrier conjugates
ITFI20060163A1 (it) * 2006-06-29 2006-09-28 Menarini Internat Operations Luxembourg Sa Composizione farmaceutica contenente un anticorpo monoclonale anti idiotipico anti-ca-125 ed alluminio

Also Published As

Publication number Publication date
SI2040749T1 (sl) 2011-06-30
MA30691B1 (fr) 2009-09-01
MX2008016059A (es) 2009-01-15
KR20090024240A (ko) 2009-03-06
US20090104184A1 (en) 2009-04-23
ES2363616T3 (es) 2011-08-10
EA015543B1 (ru) 2011-08-30
EP2228073A1 (en) 2010-09-15
DK2040749T3 (da) 2011-06-14
AR061364A1 (es) 2008-08-20
EA200900085A1 (ru) 2009-06-30
JP2009541448A (ja) 2009-11-26
NO20090395L (no) 2009-01-27
WO2008000789A3 (en) 2008-02-28
CN101478987A (zh) 2009-07-08
WO2008000789A2 (en) 2008-01-03
PT2040749E (pt) 2011-06-30
IL196148A0 (en) 2011-08-01
CA2655733A1 (en) 2008-01-03
AP2009004741A0 (en) 2009-02-28
EP2040749A2 (en) 2009-04-01
HRP20110413T1 (hr) 2011-07-31
CL2007001888A1 (es) 2008-04-18
DE602007013402D1 (de) 2011-05-05
UA95806C2 (ru) 2011-09-12
AU2007263690A1 (en) 2008-01-03
ITFI20060163A1 (it) 2006-09-28
PL2040749T3 (pl) 2011-09-30
ZA200900563B (en) 2010-03-31
ECSP099089A (es) 2009-02-27
RS51683B (en) 2011-10-31
HK1126417A1 (en) 2009-09-04
PE20080269A1 (es) 2008-05-09
EP2040749B1 (en) 2011-03-23
CY1111527T1 (el) 2015-08-05
ATE502649T1 (de) 2011-04-15
TNSN08485A1 (en) 2010-04-14
US20100040625A1 (en) 2010-02-18
CR10589A (es) 2009-03-30

Similar Documents

Publication Publication Date Title
BR112017019300A2 (pt) conjugado de fórmula genérica ama - l - x - s - ab, método para sintetizar um conjugado de fórmula genérica ama - l - x - s - ab, kit, método para sintetizar o composto ama - l - x', composição farmacêutica e método para tratar uma doença associada a células que apresentam um alvo
BR112012011328A2 (pt) inibidores de akt
MY158560A (en) Composition comprising antiboby that binds to domain ii of her2 and acidic variants thereof
BR112012029517A2 (pt) formulações de fragrância, métodos de fabricação e artigos compreendendo as mesmas.
CR20110466A (es) Anticuerpos biespecíficos anti-erbb-3/anti-c-met
EA200901319A1 (ru) Композиции для назального введения
DK2254549T3 (da) Vandige farmaceutiske sammensætninger, indeholdende borat-polyol-komplekser
BRPI0518904A2 (pt) formulaÇÕes de nepafenac tàpicas
EA201200617A1 (ru) Полимеры на основе циклодекстрина для доставки лекарственных средств
CL2012000824A1 (es) Anticuerpo que se une especificamente al epitopo que se une especificamente a un receptor epha2; conjugado de dicho anticuerpo que comprende un agente citotoxico derivado de un compuesto maitansinoide; metodo para preparar dicho conjugado; composicion farmaceutica.
ECSP11011048A (es) Inhibidores de cinasa akt y p70 s6
ECSP11011054A (es) Péptidos antivirales terapéuticos
DK2442790T3 (da) Vandige farmaceutiske sammensætninger, indeholdende borat-polyolkomplekser
CL2008002295A1 (es) Compuestos derivados de tiazolida sustituidos con alquilsulfonilos; composicion farmaceutica; y uso para el tratamiento de la hepatitis c.
EA201101116A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
BR112012009310A2 (pt) composto, e, composição farmacêutica
BRPI0713343A2 (pt) Composições farmacêuticas contendo anticorpo monoclonal anti-idiolípico anti-ca-125 e alumínio
BR112012024428A2 (pt) composição farmacêutica de dissolução rápida
BRPI0914940A8 (pt) Composições nutritivas contendo punicalaginas
WO2009083664A8 (fr) Nouvelles compositions a base de taxoides
CL2007003593A1 (es) Composicion farmaceutica que comprende fluoresceina pura; procedimiento de preparacion de la fluoresceina.
MX2011007940A (es) Conjugados de oligomero-fenotiazina.
SV2009003368A (es) Macrolidos
BRPI0519441A2 (pt) composiÇÕes compreendendo uma epotilona, suas composiÇÕes farmacÊuticas e mÉtodos de produÇço

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 6A. ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2230 DE 01/10/2013.